Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
PMDA is regarded among the most stringent regulatory bodies globally
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
The alliance directly links VivaMed’s computational drug hypotheses with Syngene’s preclinical development capabilities
The agreement ensures BIOEMTECH customers can consistently obtain Ac-225 for preclinical studies
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
Transcenta will grant EirGenix a non-exclusive license to its Highly Intensified Continuous Bioprocessing (HiCB) platform
The primary goal of the collaboration is joint research into trending and next-generation molecules
Subscribe To Our Newsletter & Stay Updated
